CDC Newsroom · Aug 5, 2026
CDC warns of Salmonella outbreak linked to jalapeños
A CDC food safety alert regarding a multistate outbreak of Salmonella linked to jalapeños
Latest medical news · page 6
The latest headlines across every section, pulled from official and open-access sources.
CDC Emerging Infections · Aug 5, 2026
Implications of Wastewater Surveillance for Clinical Care among Infectious Disease Physicians, United States, 2024
S. L. Jones et al.
CDC Emerging Infections · Aug 5, 2026
Human Myiasis Resulting from Reemergence of Cochliomyia hominivorax Screwworm, Mexico, 2025–2026
O. Delgado-Cuellar et al.
CDC Emerging Infections · Aug 5, 2026
Investigation of Mycobacterium abscessus Cluster in Hospital, Maryland, USA, 2024
S. Ludmer et al.
CDC Emerging Infections · Aug 5, 2026
Exploration of Public Perceptions of Wastewater Surveillance, United States, June 2024
J. T. Moore et al.
Fierce Biotech · Aug 5, 2026
Novo CEO accepts ‘couple of setbacks’ in R&D as CagriSema posts more mixed data
Novo Nordisk’s CEO admitted the Danish pharma has had “a couple of setbacks” in the wake of mixed data for CagriSema and its cardiovascular hopeful ziltivekimab, while stressing that the company is already on the hunt for bolt-on deals.
MedCity News · Aug 5, 2026
QuantHealth Snags $45M to Simulate Clinical Trials Before Patients Ever Enroll
QuantHealth raised $45 million in Series B funding to expand its AI platform, which simulates clinical trials before they run and predicts patient outcomes for pharma companies. The startup is aiming to cut the industry’s 90% trial failure rate and speed up the timelines for effective drugs to reach the market. The post QuantHealth Snags $45M to Simulate Clinical Trials Before Patients Ever Enroll appeared first on MedCity News .
Fierce Biotech · Aug 5, 2026
Attovia's CEO aims to scratch itch opportunity and challenge Dupixent with $289M IPO
Attovia Therapeutics has accreted a hefty $289 million from its IPO to power its anti-itch drugs through clinical development, marking another upsized listing in what has become a banner year for biotech Nasdaq debuts.
JAMA Network Open · Aug 5, 2026
Preventing Firearm-Related Suicide Deaths Among Youth
Psychiatry
JAMA Network Open · Aug 5, 2026
Operationalizing Alternate Care Facilities Before the Next Surge
Emergency Medicine
JAMA Network Open · Aug 5, 2026
Prioritizing Nursing Home Infection Prevention
Infectious Diseases
JAMA Network Open · Aug 5, 2026
The Impact of Screening on Colorectal Cancer Mortality
Gastroenterology and Hepatology
JAMA Network Open · Aug 5, 2026
Integrating Rural Background and Training Pathways Across Medical Education
Public Health
JAMA Network Open · Aug 5, 2026
Rural Background, Training, and Practice Location Among US Physicians
This cross-sectional study assesses the interdependence of rural background and training as factors associated with rural practice among US physicians.
JAMA Network Open · Aug 5, 2026
SNAP Benefit Cycles and Antiretroviral Therapy Adherence Among Adults With HIV
This cohort study examines the association between timing of receipt of Supplemental Nutrition Assistance Program (SNAP) benefits and adherence to oral antiretroviral therapy among SNAP recipients with HIV.
JAMA Network Open · Aug 5, 2026
Medical Maximizing Tendencies and Acceptance of Life Expectancy–Based Cancer Screening
This survey study evaluates how individuals who prefer to receive additionl health tests even when those tests may have limited value or cause harm (ie, medical maximizers), would respond to their clinicians’ suggestion to not undergo cancer screening on the basis of limited life expectancy.
JAMA Network Open · Aug 5, 2026
Early Outcomes of Histotripsy for Liver Tumors in US Clinical Practice
This cohort study evaluates national practice patterns and short-term outcomes of histotripsy for liver tumors among adult patients.
JAMA Network Open · Aug 5, 2026
Carrying Firearms and Suicide Risk Among Adolescents
This cross-sectional study assesses whether the carrying of firearms is associated with suicide attempts among adolescents and whether this association differs by race and ethnicity and by strength of state firearm laws.
JAMA Network Open · Aug 5, 2026
Implementation of Alternate Care Facilities During Public Health Emergencies
This qualitative study uses literature review and subject matter expert interviews to identify successes, challenges, and best practices for planning and operation of alternate care facilities in the US.
JAMA Network Open · Aug 5, 2026
Decolonization vs Enhanced Cleaning for MDRO Reduction in Nursing Homes
This quality improvement study explores the independent and combined associations of decolonization and once-daily enhanced cleaning with multidrug-resistant organism (MDRO) body-site carriage and environmental contamination in nursing homes.
JAMA Network Open · Aug 5, 2026
Colorectal Cancer Mortality Following Fecal Immunochemical Test–Based Screening
This population-based cohort study in the Basque Country, Spain, examines whether an organized fecal immunochemical test–based screening program was associated with lower colorectal cancer mortality rates from 2004 to 2024.
MedCity News · Aug 4, 2026
How Policymakers Can Improve Obesity Treatment and Affordability, Per American College of Physicians
The American College of Physicians is urging policymakers to expand access to obesity treatment and healthy foods while investing in prevention and research. The post How Policymakers Can Improve Obesity Treatment and Affordability, Per American College of Physicians appeared first on MedCity News .
FDA Recalls · Aug 4, 2026
Blank Slate Creamery Issues Allergy Alert on Undeclared Egg in Vegan Non-Dairy Frozen Dessert Coconut Fudge Sandwiches
Blank Slate Creamery of Ann Arbor, MI is recalling its 4.5 oz. packaged VEGAN NON-DAIRY FROZEN DESSERT COCONUT FUDGE SANDWICHES, because it may contain undeclared egg. People who have an allergy or severe sensitivity to eggs run the risk of serious or life-threatening allergic reaction if they consu
ACC (Cardiology) · Aug 4, 2026
Can Plasma Infrared Molecular Fingerprinting Stratify Residual Risk in Patients With CAD?
Plasma infrared molecular fingerprinting (IMF) is able to stratify residual mortality risk in patients with coronary artery disease (CAD), outperforming guideline-recommended SMART2 scores and capturing clonal haematopoiesis of indeterminate potential (CHIP)-associated biology without the need for genomic sequencing...